MarketBeat Instant News Alerts 2 hours agoCore Scientific (NASDAQ:CORZ) Releases Earnings Results, Beats Expectations By $0.39 EPSMarketBeatCore Scientific (NASDAQ:CORZ - Get Free Report) issued its earnings results on Friday. The company reported ($0.46) earnings per share for the quarter, topping the consensus estimate of ($0.85) by $0.39. NASDAQ:CORZRead Core Scientific (NASDAQ:CORZ) Releases Earnings Results, Beats Expectations By $0.39 EPS2 hours agoAquestive Therapeutics (NASDAQ:AQST) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatWeiss Ratings restated a "sell (d-)" rating on shares of Aquestive Therapeutics in a report on Friday.NASDAQ:AQSTRead Aquestive Therapeutics (NASDAQ:AQST) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (E+) Rating for Apyx Medical (NASDAQ:APYX)MarketBeatWeiss Ratings reissued a "sell (e+)" rating on shares of Apyx Medical in a research note on Friday.NASDAQ:APYXRead Weiss Ratings Reiterates Sell (E+) Rating for Apyx Medical (NASDAQ:APYX)2 hours agoAptiv's (APTV) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings restated a "hold (c)" rating on shares of Aptiv in a report on Friday.NYSE:APTVRead Aptiv's (APTV) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoAptarGroup (NYSE:ATR) Given Hold (C+) Rating at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "hold (c+)" rating on shares of AptarGroup in a research note on Friday.NYSE:ATRRead AptarGroup (NYSE:ATR) Given Hold (C+) Rating at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Buy (B-)" Rating for AppFolio (NASDAQ:APPF)MarketBeatWeiss Ratings restated a "buy (b-)" rating on shares of AppFolio in a report on Friday.NASDAQ:APPFRead Weiss Ratings Reiterates "Buy (B-)" Rating for AppFolio (NASDAQ:APPF) Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) Stock Price Down 4.9% - Here's What Happened3Nebius Group (NBIS) to Release Earnings on Wednesday4Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock5Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why6Nebius Group (NASDAQ:NBIS) Shares Down 3.9% - Time to Sell?7Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened8CoreWeave (NASDAQ:CRWV) Stock Price Down 7.2% After Insider Selling All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoApollo Global Management's (APO) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatNYSE:APORead Apollo Global Management's (APO) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoApollo Commercial Real Estate Finance (NYSE:ARI) Stock Rating Lowered by Weiss RatingsMarketBeatNYSE:ARIRead Apollo Commercial Real Estate Finance (NYSE:ARI) Stock Rating Lowered by Weiss Ratings2 hours agoApogee Therapeutics (NASDAQ:APGE) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:APGERead Apogee Therapeutics (NASDAQ:APGE) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (E+) Rating for Apellis Pharmaceuticals (NASDAQ:APLS)MarketBeatNASDAQ:APLSRead Weiss Ratings Reiterates Sell (E+) Rating for Apellis Pharmaceuticals (NASDAQ:APLS)2 hours agoWeiss Ratings Reaffirms "Buy (B-)" Rating for AON (NYSE:AON)MarketBeatNYSE:AONRead Weiss Ratings Reaffirms "Buy (B-)" Rating for AON (NYSE:AON)2 hours agoWeiss Ratings Reiterates Sell (D-) Rating for Anywhere Real Estate (NYSE:HOUS)MarketBeatNYSE:HOUSRead Weiss Ratings Reiterates Sell (D-) Rating for Anywhere Real Estate (NYSE:HOUS)2 hours agoAntero Resources (NYSE:AR) Receives Hold (C-) Rating from Weiss RatingsMarketBeatNYSE:ARRead Antero Resources (NYSE:AR) Receives Hold (C-) Rating from Weiss Ratings2 hours agoAntero Midstream's (AM) Buy (A-) Rating Reaffirmed at Weiss RatingsMarketBeatNYSE:AMRead Antero Midstream's (AM) Buy (A-) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D+) Rating for Anterix (NASDAQ:ATEX)MarketBeatNASDAQ:ATEXRead Weiss Ratings Reiterates Sell (D+) Rating for Anterix (NASDAQ:ATEX)2 hours agoWeiss Ratings Reiterates "Sell (D-)" Rating for Annexon (NASDAQ:ANNX)MarketBeatNASDAQ:ANNXRead Weiss Ratings Reiterates "Sell (D-)" Rating for Annexon (NASDAQ:ANNX)2 hours agoWeiss Ratings Reaffirms "Hold (C)" Rating for Annaly Capital Management (NYSE:NLY)MarketBeatNYSE:NLYRead Weiss Ratings Reaffirms "Hold (C)" Rating for Annaly Capital Management (NYSE:NLY)2 hours agoANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Upgraded by Weiss RatingsMarketBeatNASDAQ:ANIPRead ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Upgraded by Weiss Ratings2 hours agoAnheuser-Busch InBev SA/NV (NYSE:BUD) Receives "Hold (C-)" Rating from Weiss RatingsMarketBeatNYSE:BUDRead Anheuser-Busch InBev SA/NV (NYSE:BUD) Receives "Hold (C-)" Rating from Weiss Ratings2 hours agoAngloGold Ashanti (NYSE:AU) Upgraded at Weiss RatingsMarketBeatNYSE:AURead AngloGold Ashanti (NYSE:AU) Upgraded at Weiss Ratings2 hours agoAngioDynamics' (ANGO) Sell (D-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ANGORead AngioDynamics' (ANGO) Sell (D-) Rating Reiterated at Weiss Ratings2 hours agoAngi's (ANGI) Sell (D+) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ANGIRead Angi's (ANGI) Sell (D+) Rating Reiterated at Weiss Ratings2 hours agoAngel Oak Mortgage REIT (NYSE:AOMR) Given "Hold (C-)" Rating at Weiss RatingsMarketBeatNYSE:AOMRRead Angel Oak Mortgage REIT (NYSE:AOMR) Given "Hold (C-)" Rating at Weiss Ratings2 hours agoAnebulo Pharmaceuticals' (ANEB) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ANEBRead Anebulo Pharmaceuticals' (ANEB) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoAndretti Acquisition Corp. II's (POLE) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:POLERead Andretti Acquisition Corp. II's (POLE) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoAnavex Life Sciences' (AVXL) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:AVXLRead Anavex Life Sciences' (AVXL) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoAnaptysBio (NASDAQ:ANAB) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatNASDAQ:ANABRead AnaptysBio (NASDAQ:ANAB) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoAmylyx Pharmaceuticals (NASDAQ:AMLX) Given Sell (E+) Rating at Weiss RatingsMarketBeatNASDAQ:AMLXRead Amylyx Pharmaceuticals (NASDAQ:AMLX) Given Sell (E+) Rating at Weiss Ratings2 hours agoAmtech Systems' (ASYS) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ASYSRead Amtech Systems' (ASYS) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoAMREP (NYSE:AXR) Receives "Hold (C+)" Rating from Weiss RatingsMarketBeatNYSE:AXRRead AMREP (NYSE:AXR) Receives "Hold (C+)" Rating from Weiss Ratings Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025Robinhood warningFrom Stansberry Research (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 20252 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Buffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyFrom Banyan Hill Publishing (Ad)The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
